Alprazolam oral - Schwarz

Drug Profile

Alprazolam oral - Schwarz

Alternative Names: Alprazolam ODT; Niravam

Latest Information Update: 19 Jan 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Schwarz Pharma USA
  • Class Anxiolytics; Benzodiazepines; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Generalised anxiety disorder; Panic disorder

Most Recent Events

  • 18 Jan 2012 Azur Pharma has merged with Jazz Pharmaceuticals Inc to form Jazz Pharmaceuticals plc
  • 09 Jan 2009 Alprazolam orally disintegrating tablets exclusively licensed to Azur Pharma in USA
  • 30 Dec 2005 Launched for Generalised anxiety disorder in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top